Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Victoria M Villaflor"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
A subset of head and neck cancers arising in the oropharynx and the nasopharynx are associated with human papillomavirus or Epstein–Barr virus. Unfortunately, limited treatment options exist once patients develop recurrent or metastatic disease in
Externí odkaz:
https://doaj.org/article/4856dc2298a7432bada9c7ba0e5ec9c2
Autor:
Santosh Kesari, Alberto Bessudo, Brian R Gastman, Anthony P Conley, Victoria M Villaflor, Lisle M Nabell, DeLisa Madere, Emma Chacon, Christina Spencer, Li Li, Christopher Larson, Tony Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Minal A Barve
Publikováno v:
Future Oncology. 18:3245-3254
AdAPT-001 is an investigational therapy consisting of a replicative type 5 adenovirus armed with a TGF-β receptor-immunoglobulin Fc fusion trap, designed to neutralize isoforms 1 and 3 of the profibrotic and immunosuppressive cytokine, TGF-β. In pr
Autor:
Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Sagus Sampath, Arya Amini, Diana Bell, Victoria M. Villaflor
Publikováno v:
Current Treatment Options in Oncology.
Opinion statementNasopharyngeal carcinoma (NPC) is a rare malignancy, endemic in China, that is commonly diagnosed in locally advanced scenarios. Its pathogenesis is strongly associated with Epstein-Barr virus (EBV), an infection for which measuring
Autor:
Ari J. Rosenberg, Chih-Yi Liao, Theodore Karrison, Jonas A. de Souza, Francis P. Worden, Bernadette Libao, Monika K. Krzyzanowska, D. Neil Hayes, Eric Winquist, Vassiliki Saloura, Kevin Prescott, Victoria M. Villaflor, Tanguy Y. Seiwert, Rebecca B. Schechter, Walter M. Stadler, Ezra E.W. Cohen, Everett E. Vokes
Publikováno v:
Annals of Oncology.
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Figure 3. Genetic ablation of AXL enhances HNSCC cell line response to cisplatin, cetuximab, and radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8e6a1ebec27367d4fdb024182928b0
https://doi.org/10.1158/1078-0432.22459859
https://doi.org/10.1158/1078-0432.22459859
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d275f7ffa336e0dbd0e502100979af2
https://doi.org/10.1158/1078-0432.22459856
https://doi.org/10.1158/1078-0432.22459856
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Figure 1. AXL knockdown inhibits the migration of HNSCC cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e7d2d876ede736824c6fa37c8ca369
https://doi.org/10.1158/1078-0432.22459865
https://doi.org/10.1158/1078-0432.22459865
Supplemental Table 2 from AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Table 2. Clinical parameters and median progression-free survival in relation to AXL expression among patients with HNSCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b37a55232affcd1ba0f8ae537e925f
https://doi.org/10.1158/1078-0432.22459844
https://doi.org/10.1158/1078-0432.22459844
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279cc6a7bc09dcdc6bdca0ba336110f2
https://doi.org/10.1158/1078-0432.22459850.v1
https://doi.org/10.1158/1078-0432.22459850.v1
Autor:
Deric L. Wheeler, Randall J. Kimple, Ravi Salgia, Victoria M. Villaflor, Vassiliki Saloura, Mark W. Lingen, Parkash S. Gill, David Yang, Sandeep Saha, Bryan P. Bednarz, Tyler L. Fowler, Harsh Bahrar, Hannah E. Pearson, John P. Coan, Cara M. Braverman, Kelsey L. Corrigan, Andrew P. Stein, Mari Iida, Toni M. Brand
Supplemental Figure 2. HNSCC cell proliferation and apoptosis are not significantly impacted 24 hours post R428 treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4042e182470b4596e79af20ef2380ea4
https://doi.org/10.1158/1078-0432.22459862
https://doi.org/10.1158/1078-0432.22459862